NCT05789017View on ClinicalTrials.gov

Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Autoimmune Diseases
Interventions
DRUG

Prednisone and Mycophenolate Mofetil

Patients are treated with glucocorticoids and mycophenolate mofetil in remission induction period (6 months), during which glucocorticoids are tapered regularly and discontinued in 6 months.

DRUG

Mycophenolate Mofetil

Patients are treated with low dose mycophenolate (1-1.5g/day) during remission maintenance period for 12 months.

DRUG

Leflunomide

Patients are treated with leflunomide (20 mg/day) during remission maintenance period for 12 months.

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER